Protogenix

Ithaca, NY · Founded 2021 · Privately Held (backing)

Developer of a protein manufacturing platform designed to replace mammalian cell systems used for producing complex proteins. Protogenix is based in Ithaca, NY and was founded in 2021. Its last reported valuation was $28 million in Dec 2024. It has raised $6.8 million across 1 recorded round; the latest was a $250,000 seed round in Dec 2025.

Last reported valuation
$28.0M
Oct 2026
Priced at
—
Total raised
$6.8M
Last round
Seed Round
Dec 2025
Cap table — not yet on record

Protogenix's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Protogenix with a free account
  • ·Watch Protogenix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Protogenix

Where does Protogenix's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Protogenix's 1 recorded funding rounds.